Science and Society
Molecular life sciences research makes major contributions to societal goals such as understanding and controlling human diseases, developing new medicines, materials and foods, as well controlling diseases of plants and animals. The public, policy makers and the media take interest in many issues related to the aims, outcomes and implications of such research, which often has an ethical dimension. Among the publicly debated issues are stem cell research, personalized medicine, genetically modified organisms, food safety, and animal health and welfare.
The FEBS Science and Society Committee works at the interface between scientists, policy makers and the wider public. The Committee contributes through creating strategies and mechanisms for the shaping of policy and as a key European Federation focusing the efforts of member organizations on catalysing initiatives.
Scientific policy at the European level can be split into two strands: funding and regulation. Within the area of science funding the Committee aims to empower scientists to take a more active role in strategic plans and to enable them to speak with a unified voice. By consulting the scientific community it is much easier to generate a bottom-up approach and, most importantly, to create a vision for life sciences, which can be supported through European and national government money. The other aspect to science policy is working on the regulatory side, ensuring that there is sound scientific input into new laws and regulations that impact the life sciences. Within this, the Committee aims to champion diversity within biochemical sciences.
Working with the wider public beyond policy makers, the Committee, in collaboration with the FEBS Constituent Societies, aims to increase the understanding of biochemical science across Europe. This is particularly important as life sciences have undergone a tremendous explosion during recent years. This rapid development has resulted in a number of ethical issues and the Committee aims to provide unbiased contributions to the wider societal debate about the use of these technologies, linking to the Committee’s work on regulatory policy. As part of this objective the Committee organizes a science and society symposium at the annual FEBS Congress.
Upcoming activities – calls to FEBS Constituent Societies
Gathering views on the next EU framework program
Within our European science policy remit, the FEBS Science and Society Committee is working on how FEBS might influence the next EU framework program and would value views from FEBS Constituent Society leaders on the top priorities for the next framework. Please reply to Prof. Emmanouil Fragkoulis, Chair of the FEBS Science and Society Committee, outlining your priorities by 22nd October 2018. We would also be interested in your thoughts on any European science policy issues where you feel a collective FEBS influence might be appropriate.
Support for 'Science and Society' Constituent Society events – the Microbiome
As part of our societal remit, the FEBS Science and Society Committee runs a science and society session at the FEBS Congress, which this year explored the topic "Healthy Microbiome, Healthy Host?" (see below). The committee would like to build on this and reach a wider audience and to this end here announces a call for proposals from FEBS Constituent Societies to run a science in society event or activity under the same theme.
The exact format of the event/activity is up to the organizing society and we would like to support a range of activities from speaker events to educational activities, including for public engagement on this issue. Up to €2000 is available from FEBS to support this activity. Events or activities which involve more than one FEBS Constituent Society or which enable the sharing of an activity across Constituent Societies are encouraged.
Societies who wish to apply should check further guidelines here and submit a 1-page outline of their event/activity along with the proposed budget by 22nd October 2018. Please note that applications must come from/be endorsed by the member society and are limited to one application per FEBS member society.
FEBS-supported Science and Society Sessions for FEBS Constituent Societies on the theme of CRISPR
- Spanish Society for Biochemistry and Molecular Biology (SEBBM), 12 December 2017, Malaga (pictured above) – The role of CRISPR in Personalized Medicine: Legal and Ethical Problems. A report of this event appears on the FEBS Network here.
- Life Sciences Switzerland (LS2), 13 February 2018, Lausanne (session at Annual Meeting) – Public Panel Discussion: A Transdisciplinary Panel on CRISPR/Cas9
FEBS Congress 2018 Special Science and Society Session – Healthy microbiome, healthy host? (10 July 2018)
Whilst we have known about our fellow bacterial travellers for many years, it has only been in recent years we have realised the effect that bacteria can have on their host. This Congress session explored the surprising links between the microbiome and the host. It also considered the wider societal impact of diet, probiotics and antibiotics on the microbiome and thus the host, leading to the question of whether factors that change the microbiome should be regulated as drugs. Chairs: Emmanouil Fragkoulis, Greece; Mark Roberts, UK
• Introductory remarks, Mark Roberts, London, UK
• The oral microbiome: stability, variation and benefits, Mike Curtis, London, UK
• Microbiome and Allergy, one aspect of a complex network, Domingo Barber Hernández, Madrid, Spain
• Modulation of the gut microbiota by probiotics and prebiotics, Koen Venema, Venlo, The Netherlands
Research Integrity: A Code of Conduct
As a charitable organization, FEBS aims to advance research and education in the molecular life sciences through its journals, fellowships, courses, congress and other activities. Ethical conduct is demanded in all activities supported by FEBS. Given recent increased concerns among scientists and the public about good research practice, and following discussion of codes of conduct by the FEBS Science and Society Committee, FEBS has decided to subscribe to the 'European Code of Conduct for Research Integrity'. This document was prepared by the European Science Foundation/All European Academies, and FEBS is grateful to the European Science Foundation for permission to refer to it. The Code calls for researchers, public and private research organizations, universities and funding organizations to observe and promote the principles of integrity in scientific and scholarly research, including reliability in performing research, honesty in communication, objectivity, impartiality and independence, openness and accessibility, duty of care, fairness in providing references and giving credit, and responsibility for the scientists and researchers of the future.
Contacts with EU political officers, EMBO, ISE and other organizations have taken place in order to exchange information and coordinate activities related to science and society. In particular, under the umbrella of the BioMed Alliance, FEBS has participated in efforts to obtain from the EU the best research budget for the next Framework program (FP9), and also for inclusion of key points of interest to members of FEBS Constituent Societies such as: an increased ERC program budget, small network projects that may give rise to large projects, international labs for neighbouring countries, creation of common resource platforms such as biobanks, reinforcement of the Marie Curie program, funding for shorter stay European PhD programs, reorganization of evaluation processes, and minimization of bureaucracy.
The work of the FEBS Science and Society Committee is reported to FEBS Council and in the Science and Society Committee appendix of the FEBS Annual Report. Occasional reports also appear in FEBS News. For members of the Science and Society Committee, click here. The full terms of reference of the Committee are given in the FEBS Bylaws.
A short history
The FEBS Council approved the establishment of a Science and Society Committee, chaired by Federico Mayor, Spain, at its 27th Meeting, held in Lisbon in 2001. Alongside its other work, the Committee has organized a science and society programme at each of the FEBS annual Congresses since 2002, as summarized below.
*The past role of FEBS, together with other research organizations in Europe, in working towards the creation of the European Research Council (ERC) for investigator-driven funding within Europe is described in a recent article in Molecular Oncology:
Celis, J.E. and Gago, J.M. (2014) Shaping science policy in Europe. Mol. Oncol. 8, 447–457
Science and Society programmes at past FEBS Congresses:
2018 (Prague), Session on Healthy microbiome, healthy host?
2017 (Jerusalem), Session on The role of CRISPR in Personalized Medicine: Legal and Ethical Problems
2016 (Kuşadası – cancelled), Session was planned on GMOs: Applications to Medicine and Agronomy (two speakers shared slide sets on the Congress website in absence of live event)
2015 (Berlin), Session on Evolutionary Medicine, subtitled 'Why do we get sick?'
2014 (Paris; FEBS–EMBO Conference), Session on Safety and Security in the Biological Sciences, and Roundtable on New Trends in European Scientific Policy
2013 (St Petersburg), Workshop on Personalized Cancer Medicine
2012 (Sevilla; IUBMB–FEBS Congress), Session on AIDS, and joint workshops with FEBS, IUBMB and SEBBM Education Committees on biochemistry and molecular biology education
2011 (Torino), Session on Genetic Diseases
2010 (Gothenburg), Session on Biofuels are more than Fuels
2009 (Prague), Session on Ethics and Legislation in Stem Cell Research
2008 (Athens), Session on Biochemistry-Quality of Life-New Challenges
2007 (Vienna), (i) A town hall meeting on Re-Emerging Diseases - A Global Threat; (ii) Inclusion of Science & Society issues in a workshop on Lipids and Aging; and (iii) a Science and Society Session on Alzheimer Disease -"Aging of the Brain"
2006 (Istanbul), Session on Genetically Modified Plants: Current Status and Future Challenges
2005 (Budapest); Special Lecture on Science, Society and Public Understanding of Science
2004 (Warsaw), Session on Biological, Medical and Ethical Aspects of Stem Cell Research
2003 (Special Meeting, Brussels), Three Panel Sessions on (i) Science and Society in Europe; (ii) Stem Cell Research and Society; and (iii) Genetically Modified Organisms: Public Perception, Regulation and Role of Media
2002 (Istanbul), Panel Session on Science, Society and the Media